Central Research Laboratory, Siberian State Medical University, Moskovsky Trakt 2, Tomsk 634050, Russia.
Research School of Chemical and Biomedical Engineering, Tomsk Polytechnic University, Lenin Ave. 30, Tomsk 634050, Russia.
J Med Chem. 2024 Apr 11;67(7):5591-5602. doi: 10.1021/acs.jmedchem.3c02199. Epub 2024 Mar 20.
We propose an original strategy for metastasis prevention using a combination of three microRNAs that blocks the dedifferentiation of cancer cells in a metastatic niche owing to the downregulation of stemness genes. Transcriptome microarray analysis was applied to identify the effects of a mixture of microRNAs on the pattern of differentially expressed genes in human breast cancer cell lines. Treatment of differentiated CD44 cancer cells with the microRNA mixture inhibited their ability to form mammospheres in vitro. The combination of these three microRNAs encapsulated into lipid nanoparticles prevented lung metastasis in a mouse model of spontaneous metastasis. The mixture of three microRNAs (miR-195-5p/miR-520a/miR-630) holds promise for the development of an antimetastatic therapeutic that blocks tumor cell dedifferentiation, which occurs at secondary tumor sites and determines the transition of micrometastases to macrometastases.
我们提出了一种防止转移的新策略,该策略使用三种 microRNA 的组合,通过下调干性基因来阻止转移部位癌细胞的去分化。通过转录组微阵列分析,确定了 microRNA 混合物对人乳腺癌细胞系差异表达基因模式的影响。用 microRNA 混合物处理分化的 CD44 癌细胞,可抑制其在体外形成乳腺球体的能力。将这三种 microRNA 组合封装在脂质纳米粒中,可以防止自发转移模型中小鼠的肺转移。三种 microRNA(miR-195-5p/miR-520a/miR-630)的混合物有望开发出一种抗转移治疗药物,该药物可阻止肿瘤细胞去分化,而肿瘤细胞的去分化发生在次级肿瘤部位,并决定了微转移向大转移的转变。